InVitria’s Technology Eliminates Risks and Protects Patients

InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in...

Learn More

Weekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health

Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...

Learn More

Colorado BioScience Association Appoints Emily Martini as Vice President, Partnerships

Martini to Lead Strategic Partnerships, Initiatives, and Programs in Newly Created Role Denver – Colorado BioScience Association (CBSA) announces the appointment of Emily Martini as Vice President of...

Learn More

Weekly Policy Blog: President Biden Signs Inflation Reduction Act into Law

On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...

Learn More

Weekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements

CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....

Learn More

CBSA Remains Active on Critical Federal Legislation

Act Today and Tell Your Member of Congress: Oppose Government Price Setting Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language t...

Learn More

Weekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives

Congress is negotiating sweeping legislation that impacts life sciences. Colorado BioScience Association (CBSA) remains active on these important legislative proposals, which include supporting the re...

Learn More

Fitzsimons Innovation Community Invests to Meet Market Needs

Fitzsimons Innovation Community has maintained a fast pace of development over the past 10 years, building capacity to meet market needs. With an increase in the demand for move-in ready life sciences...

Learn More

Weekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to advance high-...

Learn More

Weekly Policy Update: Where We Stand Today on Reauthorization of SBIR/STTR

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to help advance...

Learn More